Steven Cohen Selecta Biosciences Inc Transaction History

Point72 Asset Management, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$1.64 - $3.42 $656,000 - $1.37 Million	-400,000 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$2.18 - $2.84 $1.31 Million - $1.7 Million	-600,000 Reduced 60.0%	400,000 $992,000
Q2 2020 Aug 14, 2020	BUY	$1.83 - $4.06 $249,743 - $554,076	136,472 Added 15.8%	1,000,000 $2.84 Million
Q1 2020 May 15, 2020	BUY	$1.5 - $4.52 $1.3 Million - $3.9 Million	863,528 New	863,528 $2.08 Million
Q1 2018 May 15, 2018	SELL	$8.49 - $11.82 $850,129 - $1.18 Million	-100,133 Closed	0 $0

Q4 2017 Feb 14, 2018	BUY	$8.97 - $23.38 $898,193 - $2.34 Million	100,133	100,133 $982,000

41.4M

16.8K

Ticker SELB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 152,712,992
Market Cap $128M
Description
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.